News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
495,823 Results
Type
Article (32495)
Company Profile (77)
Press Release (463251)
Multimedia
Podcasts (28)
Webinars (9)
Section
Business (135465)
Career Advice (734)
Deals (24816)
Drug Delivery (63)
Drug Development (60835)
Employer Resources (66)
FDA (14585)
Job Trends (10613)
News (241882)
Policy (24977)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2065)
Accelerated approval (4)
Adcomms (13)
Allergies (74)
Alliances (34349)
ALS (71)
Alzheimer's disease (1091)
Antibody-drug conjugate (ADC) (59)
Approvals (14615)
Artificial intelligence (200)
Autoimmune disease (17)
Automation (8)
Bankruptcy (250)
Best Places to Work (8707)
BIOSECURE Act (5)
Biosimilars (49)
Biotechnology (55)
Bladder cancer (57)
Brain cancer (22)
Breast cancer (218)
Cancer (1727)
Cardiovascular disease (141)
Career advice (658)
Career pathing (15)
CAR-T (112)
Cell therapy (290)
Cervical cancer (18)
Clinical research (50692)
Collaboration (559)
Compensation (183)
Complete response letters (14)
COVID-19 (1824)
CRISPR (22)
C-suite (166)
Cystic fibrosis (59)
Data (1813)
Decentralized trials (2)
Denatured (18)
Depression (33)
Diabetes (210)
Diagnostics (4801)
Digital health (15)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (80)
Drug pricing (74)
Drug shortages (25)
Duchenne muscular dystrophy (72)
Earnings (53150)
Editorial (25)
Employer branding (8)
Employer resources (59)
Events (68539)
Executive appointments (534)
FDA (15678)
Featured Employer (20)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (525)
Gene editing (63)
Generative AI (18)
Gene therapy (187)
GLP-1 (504)
Government (3511)
Grass and pollen (4)
Guidances (46)
Healthcare (14920)
Huntington's disease (12)
IgA nephropathy (20)
Immunology and inflammation (59)
Indications (22)
Infectious disease (1928)
Inflammatory bowel disease (104)
Inflation Reduction Act (6)
Influenza (38)
Intellectual property (70)
Interviews (88)
IPO (11583)
IRA (27)
Job creations (2260)
Job search strategy (589)
Kidney cancer (7)
Labor market (15)
Layoffs (199)
Leadership (6)
Legal (5127)
Liver cancer (64)
Lung cancer (257)
Lymphoma (113)
Machine learning (3)
Management (20)
Manufacturing (161)
MASH (49)
Medical device (13700)
Medtech (13704)
Mergers & acquisitions (13670)
Metabolic disorders (515)
Multiple sclerosis (61)
NASH (12)
Neurodegenerative disease (58)
Neuropsychiatric disorders (12)
Neuroscience (1492)
NextGen: Class of 2025 (4737)
Non-profit (3142)
Northern California (1862)
Now hiring (18)
Obesity (269)
Opinion (120)
Ovarian cancer (65)
Pain (71)
Pancreatic cancer (70)
Parkinson's disease (123)
Partnered (14)
Patents (183)
Patient recruitment (90)
Peanut (38)
People (41185)
Pharmaceutical (23)
Pharmacy benefit managers (15)
Phase I (15408)
Phase II (22169)
Phase III (17244)
Pipeline (931)
Policy (73)
Postmarket research (1883)
Preclinical (5660)
Press Release (28)
Prostate cancer (84)
Psychedelics (22)
Radiopharmaceuticals (205)
Rare diseases (250)
Real estate (3483)
Recruiting (24)
Regulatory (18038)
Reports (21)
Research institute (1867)
Resumes & cover letters (86)
Rett syndrome (4)
RNA editing (3)
RSV (29)
Schizophrenia (55)
Series A (83)
Series B (61)
Service/supplier (4)
Sickle cell disease (34)
Southern California (1585)
Special edition (5)
Spinal muscular atrophy (114)
Sponsored (21)
Startups (2502)
Stomach cancer (9)
Supply chain (47)
Tariffs (9)
The Weekly (9)
United States (16760)
Vaccines (421)
Venture capitalists (15)
Weight loss (173)
Women's health (20)
Worklife (7)
Date
Today (26)
Last 7 days (371)
Last 30 days (1864)
Last 365 days (25430)
2025 (7063)
2024 (27224)
2023 (31167)
2022 (40495)
2021 (43527)
2020 (42407)
2019 (35414)
2018 (26946)
2017 (24575)
2016 (23255)
2015 (27152)
2014 (20616)
2013 (16959)
2012 (18159)
2011 (18646)
2010 (17095)
Location
Africa (475)
Alabama (30)
Alaska (4)
Arizona (140)
Arkansas (12)
Asia (32384)
Australia (6453)
California (4195)
Canada (1634)
China (409)
Colorado (194)
Connecticut (233)
Delaware (117)
Europe (62476)
Florida (697)
Georgia (150)
Idaho (40)
Illinois (420)
India (23)
Indiana (245)
Iowa (3)
Japan (130)
Kansas (74)
Kentucky (14)
Louisiana (7)
Maine (56)
Maryland (736)
Massachusetts (2997)
Michigan (140)
Minnesota (292)
Mississippi (2)
Missouri (63)
Montana (21)
Nebraska (20)
Nevada (51)
New Hampshire (59)
New Jersey (1374)
New Mexico (14)
New York (1320)
North Carolina (718)
North Dakota (4)
Northern California (1862)
Ohio (144)
Oklahoma (4)
Oregon (25)
Pennsylvania (1082)
Puerto Rico (11)
Rhode Island (24)
South America (720)
South Carolina (18)
Southern California (1585)
Tennessee (84)
Texas (680)
Utah (136)
Virginia (114)
Washington D.C. (45)
Washington State (439)
West Virginia (3)
Wisconsin (41)
495,823 Results for "cappella medical devices limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shineco Announces Acquisition of Medical Device Company
March 26, 2025
·
5 min read
Press Releases
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products
April 1, 2025
·
4 min read
Genetown
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a limited market release of its new VASCADE MVP® XL mid-bore venous closure device.
June 18, 2024
·
4 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Business
Sysmex America Names Chris Cappella as Chief Financial Officer
Sysmex America, Inc. announced that Chris Cappella has joined the Company as Chief Financial Officer.
January 10, 2023
·
2 min read
Press Releases
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts
March 13, 2025
·
4 min read
Press Releases
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
February 24, 2025
·
4 min read
Press Releases
Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical Devices
January 28, 2025
·
3 min read
Press Releases
Viromed Medical AG: UMECO Group Acquires Exclusive Marketing Rights in Asia for Cold Plasma Medical Devices ViroCAP(R) and PulmoPlas(R)
April 2, 2025
·
4 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
1 of 49,583
Next
